You are here
P&T January 2013
To avoid more fatalities and cases of fungal meningitis, as occurred from contaminated steroid products made at the New England Compounding Center, hospitals and their pharmacy directors must stay abreast of future changes in state and federal laws regarding compounding.
The authors review the challenges in diagnosis; the roles of stress, neurotransmitters, and biological factors; cognitive–behavior therapy; and pharmacological and nonpharmacological strategies in patients with anxiety.
Novel anticoagulants represent promising alternatives to the traditional anticoagulants for VTE prophylaxis following hip and knee replacement surgery. Preliminary analyses for rivaroxaban suggest that it may be cost-effective and cost-saving in these patients.
Using a parenteral syringe to prepare or give oral or enteral liquids can be deadly
Tofacitinib (Xeljanz) for rheumatoid arthritis, perampanel (Fycompa) for partial-onset seizures, and teriflunomide (Aubagio) for relapsing multiple sclerosis